IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
100 hedge funds and large institutions have $96.5M invested in IVERIC bio, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 43 reducing their positions, and 43 closing their positions.
94% more call options, than puts
Call options by funds: $852K | Put options by funds: $440K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
15% less capital invested
Capital invested by funds: $113M → $96.5M (-$16.6M)
27% less funds holding
Funds holding: 137 → 100 (-37)
40% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 43
65% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 43
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$10.5M |
| 2 |
Morgan Stanley
New York
|
+$8.42M |
| 3 |
Renaissance Technologies
New York
|
+$7.85M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$5.17M |
| 5 |
D.E. Shaw & Co
New York
|
+$4.87M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCP
Tourbillon Capital Partners
New York
|
-$6.57M |
| 2 |
State Street
Boston,
Massachusetts
|
-$4.07M |
| 3 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
-$3.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.8M |
| 5 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$1.77M |
ISEE Hedge Fund Activity: Q1 2017 in Review
100 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2017, worth a combined $96.5M — down 15% from $113M a quarter earlier.
Sellers outnumbered buyers: 43 funds closed out of ISEE and 15 opened new positions — a net loss of 28 holders — while 43 trimmed existing stakes and 26 added.
The largest buyer was BlackRock, adding an estimated $10.5M. The largest seller was Tourbillon Capital Partners, exiting entirely with an estimated $6.57M sold.
- 100 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2017, down from 137 in Q4 2016.
- Funds reported $96.5M of IVERIC bio, Inc. Common Stock stock for Q1 2017, down 15% quarter-over-quarter.
- 15 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2017 and 43 closed out, a net change of -28 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q1 2017 was BlackRock, an estimated $10.5M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q1 2017 was Tourbillon Capital Partners, an estimated $6.57M sold.
Based on aggregated 13F filings for Q1 2017.